PharmaZell Acquired by Ergon Capital Partners
PharmaZell GmbH, a Raubling, Germany manufacturer and distributor of Active Pharmaceutical Ingredients (API) sold to both originators and generic pharmaceutical producers, has been acquired by Ergon Capital Partners II SA.
Funds advised by AUCTUS Capital Partners and Lead Equities have sold their majority stake in the company to Ergon, which will combine PharmaZell with Farmabios, its existing Italian API producer.
Founded in 1947, the company develops and produces APIs, provides services for formulation development and compiles required regulatory documents for both originators and generic pharmaceutical manufacturers.
PharmaZell, which runs three production facilities located in Raubling (Germany), Chennai (India) and Vizag (India), reported sales of € 52.4m and EBITDA of € 8.9m in the fiscal year ended March 31st 2011.